0 items USD 0.00Search
Your search for "technavio global multiple myeloma drugs market 2015 2019" gave back 819845 results.
The global Multiple Myeloma Drugs market size was valued at US$ 855 million in 2023. With growing demand in downstream market, the Multiple Myeloma...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Multiple myeloma drugs fall into various drug classes, including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable;...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global CAR T-Cell Therapy for Multiple Myeloma market size was valued at US$ 160.4 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Multiple myeloma drugs fall into various drug classes, including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents,...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Market Analysis and Insights: Global Targeted Drugs for Multiple Myeloma Market The global Targeted Drugs for Multiple Myeloma market is projected to...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Immunotherapy Drugs for Multiple Myeloma Market The global Immunotherapy Drugs for Multiple Myeloma market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Traditional Chemotherapy Drugs for Multiple Myeloma Market The global Traditional Chemotherapy Drugs for...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Multiple myeloma drugs fall into various drug classes, including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents,...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Targeted Drugs for Multiple Myeloma market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Traditional Chemotherapy Drugs for Multiple Myeloma market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Immunotherapy Drugs for Multiple Myeloma market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
